Using mobile technology to deliver a cognitive behaviour therapy-informed intervention in early psychosis (Actissist): Study protocol for a randomised controlled trial

Trials

Volumn 16, Issue 1, 2015, Pages

  Bucci, Sandra ^a   Barrowclough, Christine ^a   Ainsworth, John ^a,b   Morris, Rohan ^a   Berry, Katherine ^a   Machin, Matthew ^a,b   Emsley, Richard ^c   Lewis, Shon ^d   Edge, Dawn ^a   Buchan, Iain ^a,b   Haddock, Gillian ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Cognitive behaviour therapy; Connected health; m health; Mobile technology; Psychosis; Randomised controlled trial

Indexed keywords

ARTICLE; BEHAVIOR ASSESSMENT; CALGARY DEPRESSION SCALE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COGNITIVE THERAPY; CONTROLLED STUDY; EMOTION ASSESSMENT; EMPOWERMENT; EMPOWERMENT RATING SCALE; EUROQOL 5D 5 L; FEASIBILITY STUDY; GENERAL MENTAL DISEASE ASSESSMENT; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; INTERMETHOD COMPARISON; MENTAL DISEASE ASSESSMENT; MENTAL FUNCTION; MOBILE APPLICATION; OUTCOME ASSESSMENT; PERCEIVED CRITICISM SCALE; PERSONAL AND SOCIAL PERFORMANCE SCALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTOR VARIABLE; PROGRAM ACCEPTABILITY; PSYCHOSIS; PSYCHOTIC SYMPTOMS RATING SCALE; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RELIABILITY; SEMI STRUCTURED INTERVIEW; SINGLE BLIND PROCEDURE; TIMELINE FOLLOW BACK SCALE; TREATMENT DURATION; UNITED KINGDOM; VALIDITY; ACUTE DISEASE; BEHAVIOR; DEVICES; ENGLAND; METHODOLOGY; PATIENT SATISFACTION; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOTIC DISORDERS; QUESTIONNAIRE; RECURRENT DISEASE; SMARTPHONE; TELEMEDICINE; TIME FACTOR; TREATMENT OUTCOME;

ACUTE DISEASE; CLINICAL PROTOCOLS; COGNITIVE THERAPY; ENGLAND; FEASIBILITY STUDIES; HUMANS; MOBILE APPLICATIONS; PATIENT SATISFACTION; POWER (PSYCHOLOGY); PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUALITY OF LIFE; RECURRENCE; RESEARCH DESIGN; SINGLE-BLIND METHOD; SMARTPHONE; SURVEYS AND QUESTIONNAIRES; TELEMEDICINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84941277925     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-0943-3     Document Type: Article

References (54)

1. Kirkbride JB, Jackson D, Perez J, Fowler D, Winton F, Coid JW, et al. A population-level prediction tool for the incidence of first-episode psychosis: translational epidemiology based on cross-sectional data. BMJ Open. 2013;3(2):e001998.
2. Penn DL, Waldheter EJ, Perkins DO, Mueser KT, Lieberman JA. Psychosocial treatment for first-episode psychosis: a research update. Am J Psychiatr. 2005;162(12):2220.
3. Commission TS. The abandoned illness: a report from the Schizophrenia Commission. London: Illness RM; 2012.
4. Alvarez-Jimenez M, Priede A, Hetrick S, Bendall S, Killackey E, Parker A, et al. Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr Res. 2012;139(1):116-28.
5. Guideline NC. Psychosis and schizophrenia in adults: treatment and management, [CG178]. London: Excellence NIfHaC; 2014.
6. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull. 2008;34(3):523-37.
7. Jauhar S, McKenna P, Radua J, Fung E, Salvador R, Laws K. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry. 2014;204(1):20-9.
8. Peters E. An oversimplification of psychosis, its treatment, and its outcomes? Br J Psychiatry. 2014;205(2):159-60.
9. Haddock G, Eisner E, Boone C, Davies G, Coogan C, Barrowclough C. An investigation of the implementation of NICE-recommended CBT interventions for people with schizophrenia. J Ment Health. 2014;23(4):162-5.
10. Palmier-Claus JE, Ainsworth J, Machin M, Barrowclough C, Dunn G, Barkus E, et al. The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application. BMC Psychiatry. 2012;12(1):172.
11. Ben-Zeev D, Brenner CJ, Begale M, Duffecy J, Mohr DC, Mueser KT. Feasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophrenia. Schizophr Bull. 2014. doi: 10.1093/schbul/sbu033 .
12. Španiel F, Vohlídka P, Hrdlička J, Kožený J, Novák T, Motlová L, et al. ITAREPS: information technology aided relapse prevention programme in schizophrenia. Schizophr Res. 2008;98(1):312-7.
13. Granholm E, Ben-Zeev D, Link PC, Bradshaw KR, Holden JL. Mobile Assessment and Treatment for Schizophrenia (MATS): a pilot trial of an interactive text-messaging intervention for medication adherence, socialization, and auditory hallucinations. Schizophr Bull. 2011. doi: 10.1093/schbul/sbr155 .
14. Kay SR, Flszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261.
15. Haddock G, McCarron J, Tarrier N, Faragher E. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999;29(04):879-89.
16. Drake R, Haddock G, Tarrier N, Bentall R, Lewis S. Psychotic Symptom Rating Scales (PSYRATS): their usefulness and properties in first episode psychosis. Schizophr Res. 2007;89:119-22.
17. Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res. 1990;3(4):247-51.
18. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II.San Antonio, TX:Psychological Corporation; 1996.
19. Trower P, Birchwood M, Meaden A, Byrne S, Nelson A, Ross K. Cognitive therapy for command hallucinations: randomised controlled trial. Br J Psychiatry. 2004;184:312-20.
20. Association AP. Diagnostic and Statistical Manual. Washington (DSM IV). 4th ed. Washington, DC: APA; 1994.
21. Morosini P, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand. 2000;101(4):323-9.
22. Rogers ES, Chamberlin J, Ellison ML, Crean T. A consumer-constructed scale to measure empowerment among users of mental health services. Psychiatr Serv. 1997;48(8):1042-7.
23. Group E. EuroQol - a new facility for the measurement of health-related quality of life. Health Pol. 1990;16:199-208.
24. Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: RZ L, JP A, editors. Measuring alcohol consumption. Totowa: Humana Press; 1992. p. 41-72.
25. Carey KB, Carey MP, Maisto SA, Henson JM. Temporal stability of the timeline followback interview for alcohol and drug use with psychiatric outpatients. J Stud Alcohol. 2004;65(6):774.
26. Hooley JM, Teasdale JD. Predictors of relapse in unipolar depressives: expressed emotion, marital distress, and perceived criticism. J Abnorm Psychol. 1989;98(3):229-35.
27. Riso LP, Klein DN, Anderson RL, Ouimette PC, Lizardi H. Covergent and discriminant validity of perceived criticism from spouses and family members. Behav Ther. 1996;27(2):129-37.
28. Chambless DL, Steketee G. Expressed emotion and behavior therapy outcome: a prospective study with obsessive-compulsive and agoraphobic outpatients. J Consult Clin Psychol. 1999;67(5):658.
29. Thompson K, Kulkarni J, Sergejew A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42(3):241-7.
30. Ainsworth J, Palmier-Claus JE, Machin M, Barrowclough C, Dunn G, Rogers A, et al. A comparison of two delivery modalities of a mobile phone-based assessment for serious mental illness: native smartphone application vs text-messaging only implementations. J Med Internet Res. 2013;15(4):e60.
31. Morrison AP. The interpretation of intrusions in psychosis: an integrative cognitive approach to hallucinations and delusions. Behav Cogn Psychother. 2001;29(03):257-76.
32. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington P. A cognitive model of the positive symptoms of psychosis. Psychol Med. 2001;31(02):189-95.
33. Morrison AP, Barratt S. What are the components of CBT for psychosis? A Delphi study Schizophr Bull. 2010;36(1):136-42.
34. Roth AD, Pilling S. A competence framework for psychological interventions with people with psychosis and bipolar disorder. In. Edited by Research Department of Clinical EaHP, UCL; 2012
35. Baker A, Bucci S, Lewin TJ, Kay-Lambkin F, Constable PM, Carr VJ. Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial. Br J Psychiatry. 2006;188:439-48.
36. Barrowclough C, Haddock G, Wykes T, Beardmore R, Conrod P, Craig T, et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ. 2010;341:c6325.
37. Berry K, Barrowclough C, Haddock G. The role of expressed emotion in relationships between psychiatric staff and people with a diagnosis of psychosis: a review of the literature. Schizophr Bull. 2011;37(5):958-72.
38. Bucci S, Tarrier N. Schizophrenia and psychotic disorders. In: Hofman SG, Reinecke MA, editors. Cognitive-behavioural therapy with adults: a guide to empirically informed assessment and interventions. Cambridge: Cambridge University Press; 2010. p. 135-48.
39. Freeman D, Freeman J, Garety PA. Overcoming paranoid and suspicious. Robinson; 2012
40. Haddock G, Berry K, Davies G, Dunn G, Hartley S, Kelly J et al. Delivery preferences for recovery focused cognitive behaviour therapy for psychosis: a preference trial. Br J Psychiatr. 2015, in press.
41. Haddock G, Lewis S. Psychological interventions in early psychosis. Schizophr Bull. 2005;31(3):697-704.
42. Meaden A, Keen N, Aston R, Barton K, Bucci S. Cognitive therapy for command hallucinations: an advanced practical companion. Hove: Routledge; 2013.
43. Wells A. Cognitive therapy of anxiety disorders: a practice manual and conceptual guide. London: Wiley; 1997.
44. Tarrier N, Harwood S, Yusopoff L, Beckett R, Baker A. Coping strategy enhancement (CSE): a method of treating residual schizophrenic symptoms. Behav Psychother. 1990;18(04):283-93.
45. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-81.
46. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004;10(2):307-12.
47. Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol. 2012;65(3):301-8.
48. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4(4):287-91.
49. Approved Cryptographic Algorithms Good Practice Guideline, Crown Copyright. Available online at: http://systems.hscic.gov.uk/infogov/security/infrasec/gpg/acs.pdf .
50. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
51. Ritchie J, Lewis J. Qualitative research practice: a guide for social science students and researchers. London: Academic Press; 2003.
52. Gibson W, Brown A. Working with qualitative data. Sage; 2009
53. Martin DJ, Garske JP, Davis MK. Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review. J Consult Clin Psychol. 2000;68(3):438.
54. Cavanagh K, Millings A. (Inter) personal computing: the role of the therapeutic relationship in e-mental health. J Contemp Psychother. 2013;43(4):197-206.